A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

(MENAFN) Russia’s Gamaleya Research Institute, known for developing the Sputnik V COVID-19 vaccine, is close to gaining regulatory approval for a personalized mRNA cancer vaccine. According to ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

To counteract these challenges, novel strategies aim to restore the cancer immunity cycle. One approach involves directly injecting unadjuvanted influenza vaccines or drug-loaded oncolytic viruses ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

Modern medicine is helping clinicians tailor cancer treatments for individuals and Birmingham researchers are at the ...

Breast cancer cases in Americans under 45 years old dramatically increased after the introduction of mRNA COVID-19 vaccines, from approximately 26,000 in 2019-2022 to 297,000 in 2023, a nearly 1,000% ...

The vaccine acts like a "wanted poster" unmasking cancer cells that are adept at hiding in the body, only to resurface later.

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...